Milano-Bicocca University, Milan, Italy.
Ukrainian Scientific Research Institute of Transport, Odesa, Ukraine.
Ann Nutr Metab. 2020;76 Suppl 1:69-70. doi: 10.1159/000515276. Epub 2021 Mar 29.
In observational studies, increased water intake improves kidney function but not in adults with CKD stage 3 and more. CKD WIT trial has shown a nonsignificant gradual decline in kidney function after 1 year of coaching to increase water intake (CIWI) [
Parallel-group randomized trial was aimed to determinate the effectiveness of CIWI dependence of estimated glomerular filtration rate (eGFR) stage and RFR in adults with CKD 1-2 stages.
CKD WIT trial was taken as the basis for prospective multicenter randomized trial named "Early Coaching to Increase Water Intake in CKD (ECIWIC)." The primary outcome was the change in kidney function by eGFR from baseline to 12 months. Secondary outcomes included 1-year change in urine albumin/Cr ratio, and patient-reported overall quality of health (QH) ranged from 0 (worst possible) to 10 (best possible). CIWI aimed to have the diuresis being 1.7-2 L. There were 4 groups with nondiet sodium restriction which consisted of 31 patients each: 2 groups with CKD G1 and CKD G2, undergoing CIWI and 2 others with CKD G1 and CKD G2 without CIWI (Fig. 1a). Overall checks were made at 0, 6, and 12 months. RFR evaluation was performed using 0.45% sodium chloride oral solution.
Of our randomized 124 patients (mean age 53.2 years; men 83 [67%], 0 died), mean change in 24-h urine volume was 0.6 L per day in G1 with CIWI group and 0.5 L in G2. No statistically significant data on eGFR depending CIWI were obtained (Fig.
With CKD G1, the CIWI leads to the preservation of the renal function with its increase of GFR per 1 mL/min/m2/per year in comparison with the same water intake. In CKD G2, the CIWI prevents physiological and pathological loss of renal function, and RFR above 50% aids restoration of eGFR both in CKD G1-2. ECIWIC trial demonstrates benefit of CIWI in patients with CKD 1-2 and preserved RFR.
在观察性研究中,增加水的摄入量可以改善肾功能,但在 3 期及以上的 CKD 患者中则不然。CKD WIT 试验表明,在接受增加水摄入量的 1 年教练指导后,1 年后肾功能逐渐下降(CIWI)[1]。我们提出,CIWI 可能对 CKD 1-2 期(G1 和 G2)有益,并且取决于功能性肾功能储备(RFR)[2,3]。
本平行组随机试验旨在确定 CIWI 对 eGFR 分期和 RFR 依赖的 CKD 1-2 期成人水摄入量增加的有效性。
以 CKD WIT 试验为基础,开展了一项名为“早期增加水摄入以改善 CKD(ECIWIC)”的前瞻性多中心随机试验。主要结局是 eGFR 从基线到 12 个月的变化。次要结局包括 1 年尿白蛋白/肌酐比值的变化,以及患者报告的整体健康状况(QH),范围从 0(最差)到 10(最好)。CIWI 的目标是每天有 1.7-2 L 的尿量。共有 4 组不限制钠饮食,每组 31 例:2 组 CKD G1 和 CKD G2 接受 CIWI,另外 2 组 CKD G1 和 CKD G2 不接受 CIWI(图 1a)。在 0、6 和 12 个月时进行全面检查。RFR 评估采用 0.45%氯化钠口服液进行。
我们随机分配的 124 例患者(平均年龄 53.2 岁;男性 83 例[67%],无死亡),24 小时尿量平均每天增加 0.6 L,G1 组 CIWI 组增加 0.5 L,G2 组增加 0.5 L。未获得 CIWI 对 eGFR 的统计学显著数据(图 1b)。然而,趋势表明 CIWI 可改善 CKD G1 的 eGFR(从 95 增加到 96 mL/min/1.73 m2),并维持 CKD G2 的 eGFR 下降(从 78 到 78)。QH 值也得到了保留(G1 和 G2 组均为 7 到 7)。尽管保持相同的水摄入量的指导并没有保留 CKD G1-2 患者的生理和病理 eGFR 下降(G1 从 96 下降到 93,G2 从 76 下降到 73;t = 0.6,p = 0.29,所有组 p ≤ 0.05)和 QH 下降(两组均从 7 下降到 6)。对 RFR 的个体分析表明,RFR 超过 50%的患者(G1 19 例,61%,G2 13 例,42%),CIWI 可可靠地保留 eGFR,同时增加 1.5 mL/min,而 RFR 较低的患者在 12 个月内 eGFR 下降 1.1 mL/min/m2。血清钠水平正常偏低的患者在 CIWI 上的结果较差。
在 CKD G1 中,CIWI 可增加 GFR 增加 1 毫升/分钟/毫升/年,从而维持肾功能。在 CKD G2 中,CIWI 可预防生理和病理性肾功能丧失,RFR 超过 50%可在 CKD G1-2 中恢复 eGFR。ECIWIC 试验表明,CIWI 对 CKD 1-2 期且保留 RFR 的患者有益。